Aging is a complex process that is linked to an increased incidence of major diseases such as cardiovascular and neurodegenerative disease, but also cancer and immune disorders. MicroRNAs (miRNAs) are small non‐coding RNAs, which post‐transcriptionally control gene expression by inhibiting translation or inducing degradation of targeted mRNAs. MiRNAs target up to hundreds of mRNAs, thereby modulating gene expression patterns. Many miRNAs appear to be dysregulated during cellular senescence, aging and disease. However, only few miRNAs have been so far linked to age‐related changes in cellular and organ functions. The present article will discuss these findings, specifically focusing on the cardiovascular and neurological systems. This review is part of the small RNAs review series. See more reviews from this series. http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1757‐4684/homepage/reviews_smallrnas.htm
No takes yet. Share an insight, caveat, or question.
Dimmeler et al. (2013) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: